Earnings History Data for Rezolute (RZLT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Rezolute
Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | RZLT | Rezolute | 304.00 | -0.22 | -0.35 | 0.00 | Rezolute GAAP EPS of -$0.22 [11/8/2024 6:27 AM] |
5.62 | -0.10 (-1.75%) |
5.70 | -0.02 (-0.35%) |
0.72 - 6.10 | 462,860 | 360,000 | 1,325 | ||
| 13-02-2024 | AH | RZLT | Rezolute | 42.00 | -0.27 | -0.27 | 0.00 | 1.18 | 0.09 (8.26%) |
1.17 | 0.08 (7.34%) |
0.72 - 2.77 | 494,693 | 130,000 | 14,080 | |||
|
|
||||||||||||||||||
| 13-11-2023 | PM | RZLT | Rezolute | 31.00 | -0.28 | -0.33 | 0.00 | Rezolute GAAP EPS of -$0.28 in-line [11/14/2023 2:19 AM] |
0.8093 | -0.04 (-5.12%) |
0.0 | 0.0 (0.00%) |
0.72 - 2.90 | 108,983 | 30,000 | 0 | ||
| 14-09-2023 | AH | RZLT | Rezolute | 53.00 | -0.25 | -0.34 | 0.00 | Rezolute GAAP EPS of -$0.25 beats by $0.11 [9/14/2023 4:26 PM] |
1.51 | -0.04 (-2.41%) |
1.55 | 0.0 (0.00%) |
1.34 - 3.20 | 36,461 | 30,000 | 15,439 | ||
| 11-05-2023 | PM | RZLT | Rezolute, Inc. | 74.76 | -0.30 | -0.31 | -0.65 | Rezolute GAAP EPS of -$0.30 in-line [5/12/2023 6:55 AM] |
2.07 | 0.04 (1.98%) |
0.0 | 0.0 (0.00%) |
1.34 - 3.59 | 2,063 | 20,000 | 0 | ||
| 10-02-2023 | AH | Before the open (Feb 10) |
RZLT | Rezolute | 101.00 | -0.26 | -0.33 | 0.00 | Rezolute GAAP EPS of -$0.26 beats by $0.05 [2/10/2023 4:08 PM] |
2.60 | -0.18 (-6.47%) |
0.0 | 0.0 (0.00%) |
1.34 - 4.83 | 6,874 | 20,000 | 0 | |
|
|
||||||||||||||||||
| 09-11-2022 | AH | RZLT | Rezolute | 67.00 | -0.19 | -0.31 | 0.00 | Rezolute GAAP EPS of -$0.19 [11/9/2022 5:27 PM] |
1.67 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
1.54 - 6.70 | 22,032 | 280,000 | 0 | ||
| 15-09-2022 | AH | RZLT | Rezolute | 85.00 | -0.37 | -0.34 | 0.00 | Rezolute GAAP EPS of -$0.37 [9/15/2022 4:23 PM] |
2.71 | 0.01 (0.19%) |
0.0 | 0.0 (0.00%) |
2.06 - 9.44 | 19,790 | 30,000 | 0 | ||
| 12-05-2022 | AH | RZLT | Antriabio | 54.00 | -0.65 | -0.86 | 0.00 | Rezolute GAAP EPS of -$0.65 [5/12/2022 5:21 PM] |
3.52 | 0.27 (8.31%) |
3.25 | 0.0 (0.00%) |
2.26 - 17.39 | 26,363 | 130,000 | 326 | ||
| 12-11-2021 | AH | RZLT | Rezolute, Inc. | 103.47 | -0.92 | -0.90 | -0.62 | Rezolute EPS misses by $0.02 [11/12/2021 4:11 PM] |
6.17 | -0.13 (-2.06%) |
6.30 | 0.0 (0.00%) |
5.86 - 21.00 | 25,707 | 40,000 | 2,907 | ||
| 15-09-2021 | AH | RZLT | Antriabio, Inc. | 81.00 | -0.78 | -0.82 | 0.00 | Rezolute EPS beats by $0.03 [9/15/2021 5:10 PM] |
8.73 | -0.93 (-9.67%) |
0.0 | 0.0 (0.00%) |
5.86 - 24.05 | 17,708 | 20,000 | 0 | ||